QIAreach SARS-CoV-2 antigen test, developed in collaboration with Ellume, is easy to use and provides accurate and objective results in 2 to 15 minutes
This work has been published in the journal ‘ACS applied materials and interface’
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
CDSCO to fast-track trials and approval for COVID19 vaccine
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
Five seats reserved for Wards of COVID warriors in central MBBS admission
Robust demand for the product across the Middle East, Africa and Latin America
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Subscribe To Our Newsletter & Stay Updated
